Structures of the T cell potassium channel Kv1.3 with immunoglobulin modulators

被引:42
|
作者
Selvakumar, Purushotham [1 ]
Fernandez-Marino, Ana I. [2 ]
Khanra, Nandish [1 ]
He, Changhao [1 ]
Paquette, Alice J. [3 ]
Wang, Bing [3 ]
Huang, Ruiqi [4 ,5 ]
Smider, Vaughn V. [4 ,5 ,6 ]
Rice, William J. [3 ,7 ]
Swartz, Kenton J. [2 ]
Meyerson, Joel R. [1 ]
机构
[1] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA
[2] NINDS, Mol Physiol & Biophys Sect, Porter Neurosci Res Ctr, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA
[3] NYU, Sch Med, Cryoelect Microscopy Core, New York, NY USA
[4] Appl Biomed Sci Inst, San Diego, CA USA
[5] Minotaur Therapeut, San Diego, CA USA
[6] Scripps Res Inst, Dept Mol Med, La Jolla, CA 92037 USA
[7] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA
基金
美国国家卫生研究院;
关键词
C-TYPE INACTIVATION; SHAKER K+ CHANNELS; SUBUNIT STOICHIOMETRY; LYMPHOCYTE FUNCTION; CRYSTAL-STRUCTURE; PORE MUTATIONS; ION CHANNELS; VOLTAGE; CHARYBDOTOXIN; BLOCKER;
D O I
10.1038/s41467-022-31285-5
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The Kv1.3 potassium channel is expressed abundantly on activated T cells and mediates the cellular immune responses. Here, the authors report structures of the Kv1.3 potassium channel with and without immunoglobulin modulators, shedding light on the mechanisms of Kv1.3 gating and modulation. The Kv1.3 potassium channel is expressed abundantly on activated T cells and mediates the cellular immune response. This role has made the channel a target for therapeutic immunomodulation to block its activity and suppress T cell activation. Here, we report structures of human Kv1.3 alone, with a nanobody inhibitor, and with an antibody-toxin fusion blocker. Rather than block the channel directly, four copies of the nanobody bind the tetramer's voltage sensing domains and the pore domain to induce an inactive pore conformation. In contrast, the antibody-toxin fusion docks its toxin domain at the extracellular mouth of the channel to insert a critical lysine into the pore. The lysine stabilizes an active conformation of the pore yet blocks ion permeation. This study visualizes Kv1.3 pore dynamics, defines two distinct mechanisms to suppress Kv1.3 channel activity with exogenous inhibitors, and provides a framework to aid development of emerging T cell immunotherapies.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] The potassium channel Kv1.3 as a therapeutic target for immunocytoprotection after reperfusion
    Chen, Yi-Je
    Cui, Yanjun
    Singh, Latika
    Wulff, Heike
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2021, 8 (10): : 2070 - 2082
  • [22] Potassium secretion by voltage-gated potassium channel Kv1.3 in the rat kidney
    Carrisoza-Gaytan, Rolando
    Salvador, Carolina
    Satlin, Lisa M.
    Liu, Wen
    Zavilowitz, Beth
    Bobadilla, Norma A.
    Trujillo, Joyce
    Escobar, Laura I.
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2010, 299 (01) : F255 - F264
  • [23] Characterization of endogenous Kv1.3 channel isoforms in T cells
    Serna, Julia
    Peraza, Diego A.
    Moreno-Estar, Sara
    Saez, Juan J.
    Gobelli, Dino
    Simarro, Maria
    Hivroz, Claire
    Lopez-Lopez, Jose R.
    Cidad, Pilar
    de la Fuente, Miguel A.
    Perez-Garcia, M. Teresa
    JOURNAL OF CELLULAR PHYSIOLOGY, 2023, 238 (05) : 976 - 991
  • [24] Characterization of endogenous Kv1.3 channel isoforms in T cells
    Serna, Julia
    Moreno-Estar, Sara
    Peraza, Diego A.
    Gobelli, Dino
    Simarro, Maria
    Lopez Lopez, Jose R.
    Cidad, Pilar
    de la Fuente, Miguel A.
    Perez-Garcia, M. Teresa
    BIOPHYSICAL JOURNAL, 2022, 121 (03) : 385A - 386A
  • [25] The Mitochondrial Routing of the Kv1.3 Channel
    Capera, Jesusa
    Navarro-Perez, Maria
    Moen, Anne Stine
    Szabo, Ildiko
    Felipe, Antonio
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [26] Open channel block of Kv1.3 by rosiglitazone and troglitazone: Kv1.3 as the pharmacological target for rosiglitazone
    Hye Sook Ahn
    Sung Eun Kim
    Hyun-Jong Jang
    Myung-Jun Kim
    Duck-Joo Rhie
    Shin-Hee Yoon
    Yang-Hyeok Jo
    Myung-Suk Kim
    Ki-Wug Sung
    Seong Yun Kim
    Sang June Hahn
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2007, 374 : 305 - 309
  • [27] Open channel block of Kv1.3 by rosiglitazone and troglitazone: Kv1.3 as the pharmacological target for rosiglitazone
    Ahn, Hye Sook
    Kim, Sung Eun
    Jang, Hyun-Jong
    Kim, Myung-Jun
    Rhie, Duck-Joo
    Yoon, Shin-Hee
    Jo, Yang-Hyeok
    Kim, Myung-Suk
    Sung, Ki-Wug
    Kim, Seong Yun
    Hahn, Sang June
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2007, 374 (04) : 305 - 309
  • [28] Electromagnetic field affects the voltage-dependent potassium channel Kv1.3
    Cecchetto, C.
    Maschietto, M.
    Boccaccio, P.
    Vassanelli, S.
    ELECTROMAGNETIC BIOLOGY AND MEDICINE, 2020, 39 (04) : 316 - 322
  • [29] Actinomycin D-induced apoptosis involves the potassium channel Kv1.3
    Bock, J
    Szabó, I
    Jekle, A
    Gulbins, E
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 295 (02) : 526 - 531
  • [30] Inhibition of the potassium channel Kv1.3 reduces infarction and inflammation in ischemic stroke
    Chen, Yi-Je
    Nguyen, Hai M.
    Maezawa, Izumi
    Jin, Lee-Way
    Wulff, Heike
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2018, 5 (02): : 147 - 161